Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.

Brona Loughrey; Ann McGinty; Ian Young; David McCance; Lesley Powell

Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.

Brona Loughrey
, Ann McGinty
, Ian Young
, David McCance
, Lesley Powell

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Clinical Endocrinology
Publication status	Accepted - 2013

Cite this

@article{b95593ca345e4e64b04885304849a0df,

title = "Increased circulating CC chemokine levels in metabolic syndrome are reduced by low dose atorvastatin treatment: evidence from a randomised controlled trial.",

author = "Brona Loughrey and Ann McGinty and Ian Young and David McCance and Lesley Powell",

year = "2013",

language = "English",

journal = "Clinical Endocrinology",

publisher = "Wiley-Blackwell",

}